Profitability
This table compares Escalon Medical and Remedent’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Escalon Medical | 0.88% | 7.73% | 2.16% |
| Remedent | N/A | N/A | N/A |
Risk & Volatility
Escalon Medical has a beta of 0.25, suggesting that its stock price is 75% less volatile than the S&P 500. Comparatively, Remedent has a beta of -0.3, suggesting that its stock price is 130% less volatile than the S&P 500.
Valuation & Earnings
This table compares Escalon Medical and Remedent”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Escalon Medical | $12.05 million | 0.10 | $110,000.00 | ($0.02) | -8.50 |
| Remedent | $990,000.00 | 0.01 | -$270,000.00 | ($0.01) | -0.03 |
Escalon Medical has higher revenue and earnings than Remedent. Escalon Medical is trading at a lower price-to-earnings ratio than Remedent, indicating that it is currently the more affordable of the two stocks.
Summary
Escalon Medical beats Remedent on 7 of the 9 factors compared between the two stocks.
About Escalon Medical
Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea. The company also provides Ispan Intraocular Gases, such as C3F8 and SF6 that are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and AXIS Image management system for managing ophthalmic diagnostic images through the web browser from various devices. In addition, it markets disposable surgical packs used in vitreoretinal surgery, including packs that aid surgeons in the process of injecting and extracting silicone oil. Further, the company engages in the manufacturing and distribution of patented disposable universal gas kit, which delivers the gas from the canister to the patient. It sells its products to medical institutions through independent sales representatives, network of distributors, and internal sales employees. Escalon Medical Corp. was incorporated in 1987 and is headquartered in Wayne, Pennsylvania.
About Remedent
Remedent, Inc. researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products in the United States and internationally. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company also offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. In addition, it provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient’s teeth. Further, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice that enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Additionally, it provides dental implant solutions and treatment concepts. The company sells its products through internal sales force and third party distributors. Remedent, Inc. was incorporated in 1986 and is headquartered in Ghent, Belgium.
Receive News & Ratings for Escalon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Escalon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
